BioSpace News Archive

Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Chairman and Chief Executive Officer, Kevin Hrusovsky will present virtually at The Cowen 42nd Annual Health Care Conference on March 9, 2022 at 9:50 a.m., EST.

Aurinia Pharmaceuticals Inc. announced that members of the executive management team will give corporate presentations at two upcoming investor conferences including.

The demand within the global market for leadless pacing systems has been rising on account of advancements in the field of cardiac treatments.

Albany NY, United States: The global market for fluid warmer devices has been rising on account of advancements in the field of surgical procedures.

Bivalirudin is a synthetic residue peptide and it is direct thrombin inhibitor. It is an anticoagulant that helps to prevent the formation of blood clots, especially in people with severe chest pain or ones who are undergoing angioplasty.

Albany NY, United States: Abetalipoproteinemia is an inborn metabolic disorder. It has a heterogeneous interpreted clinical presentation.

The New England Journal of Medicine published detailed results from a Phase 3 trial evaluating nirsevimab, the first investigational long-acting antibody designed to protect all infants across the respiratory syncytial virus season with a single dose.

Emollivet, a subsidiary of Lipidor AB, is now launching Emollivet COMBI: an antiseptic emollient spray for horses with pastern dermatitis.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the fourth quarter and full year ended December 31, 2021, and provides a corporate update.

Zealand Pharma A/S announced that it will host a conference call on March 10, 2022 at 4 pm CET following the announcement of results for the full year of 2021.